Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 807.65
+1.60 (0.20%)
Oct 21, 2026, 3:29 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 199.02 billion as of October 21, 2026. Its market cap has increased by 45.05% in one year.
Market Cap
199.02B
Enterprise Value
204.79B
Revenue
56.32B
Global Rank
n/a
Country Rank
n/a
PE Ratio
29.97
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 199.02B, an increase of 121,474.83%. That is a compound annual growth rate of 34.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 199.02B | 37.02% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 415.91B |
| Emcure Pharmaceuticals | 345.33B |
| Wockhardt | 317.66B |
| Piramal Pharma | 262.84B |
| Cohance Lifesciences | 177.54B |
| Alivus Life Sciences | 160.73B |
| Eris Lifesciences | 158.77B |
| Alembic Pharmaceuticals | 155.18B |